ClinicalTrials.gg
CompletedNCT05832242Updated Oct 19, 2026

Developing a Decision Tool for Diverticulitis in the Emergency Department Using Ultrasound

An observational study in Diverticulitis, sponsored by Northwell Health. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Northwell Health · Observational

Updated Oct 19, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,125
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to create a decision tool using ultrasound, patient history, and laboratory values to predict a diagnosis of complicated diverticulitis and whether the patient requires further imaging. The accuracy of the decision tool will be evaluated. This study will also assess the ability of ultrasound to diagnose complicated and simple diverticulitis, and the inter-provider reliability of ultrasound interpretation of diverticulitis

02

Conditions studied

  • Diverticulitis

Browse trials for

03

In context

Diverticulitis

125 studies on the registry are indexed under Diverticulitis; 22 are open to participants now.

This study's enrollment of 1,125 is above the median of 275 across 59 observational studies indexed under Diverticulitis.

Browse Diverticulitis studies →

Lead sponsor

Northwell Health is the lead sponsor of 475 studies on the registry; 107 are open to participants now.

Of its 45 completed or terminated interventional studies of FDA-regulated products, 23 (51%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult emergency department patients suspected of having diverticulitis.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Emergency department patient
  • Provider suspicion of diverticulitis
  • CT scan ordered

Exclusion criteria

Exclusion Criteria:

  • Pregnant patient
  • Prisoner
  • Non-English speaking
  • Inability to provide
  • Hemodynamically unstable as determined by provider
  • Previous abdominal surgery within last 7 days
  • Unable to lay flat for ultrasound exam
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,125 participants (actual)
Patient registry
No

Groups and cohorts

  • Simple Diverticulitis

    Computed tomograpy scan showing isolated inflammation

    Other: Ultrasound

  • Complicated Diverticulitis

    Computed tomograpy scan evidence of diverticulitis with either an associated abscess, fistula, obstruction, bleeding, phlegmon or perforation.

    Other: Ultrasound

Interventions

  • OtherUltrasound

    Point-of-care ultrasound in the emergency department

06

What researchers measure

Primary outcomes

  1. Simple Diverticulitis

    Computed tomography scan showing isolated inflammation

    Time frame: 48 hours

07

Study locations

1 site
  • North Shore University Hospital
    Manhasset, New York 11030, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2023 to primary completion in Feb 2026, 35 months.

Of 22 observational studies under Diverticulitis, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 101. This study's 35 months is below that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 19, 2026: primary completion Feb 2025 → Feb 2026 and completion Feb 2025 → Feb 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 15, 2023
First posted
Apr 27, 2023
StartActual
Feb 28, 2023
Primary completionActual
Feb 16, 2026was Feb 2025
CompletionActual
Feb 16, 2026was Feb 2025
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Status unknown→Completed
changed Oct 19, 2026
Primary completion
Feb 28, 2025→Feb 16, 2026 (actual)
Oct 19, 2026
Study completion
Feb 28, 2025→Feb 16, 2026 (actual)
Oct 19, 2026
Enrollment
4000 (estimated)→1125 (actual)
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    Status unknown→Completed
    Primary completion Feb 28, 2025→Feb 16, 2026 (now actual)
    Study completion Feb 28, 2025→Feb 16, 2026 (now actual)
    Enrollment 4000 (estimated)→1125 (actual)
    + 3 other changes: contact details, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05832242
Lead sponsor
Northwell Health
Responsible party
Sponsor
First posted
Apr 27, 2023
Start date
Feb 28, 2023
Primary completion
Feb 16, 2026
Completion
Feb 16, 2026
Last update
Oct 19, 2026

Study contacts

Allison Cohen, MD
principal investigator · Northwell Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion